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Background: Growing evidence indicates that iron-deﬁciency anemia is common in patients with con-
genital heart diseases.
The aim of this study was to characterize hematologic changes and iron metabolism in adult Fontan
patients. We also searched for the associations between these parameters and physical performance in
the study group.
Methods and results: Thirty-two white Fontan patients with a mean age of 25±4.5 years and 30 healthy
control subjects matched for age and sex were studied. Complete blood count together with iron-related
parameters was determined in plasma of peripheral venous blood. The cardiopulmonary exercise test
was performed.
The Fontanpatients hadhigher red blood cell counts (6.0±2.1×109/l vs. 4.8±0.4×109/l, p<0.001),
hemoglobin (16.7±1.4 g/dl vs. 14.2±1.3 g/dl, p<0.001), hematocrit (49±3.4% vs. 42.1±3.1%, p<0.001),
red cell distributionwidth (RDW) (14.3±2.4% vs. 12.8±0.5%, p<0.001), whilemean corpuscular volume,
mean corpuscular hemoglobin, and mean corpuscular hemoglobin concentration were similar in both
the groups. Compared to the controls, the Fontan patients had higher unsaturated iron binding capac-
ity (46.1±12.6mol/l vs. 38.4±11.9mol/l, p=0.02), total iron-binding capacity (62.8±9.8mol/l vs.
57.8±8.5mol/l, p=0.04), lower transferrin saturation (27.4±11.4% vs. 34.6±13.4%, p=0.03), and oxy-
gen uptake, while iron and ferritin levels were comparable in both the groups. The multivariate model
showed that SatO2 and cystatin C were independent predictors of RDW, and alanine aminotransferase
was an independent predictor of ferritin level. Interestingly RDWwas an independent predictor of oxygen
uptake.
Conclusion: Adult patients after Fontan operation despite having increased hemoglobin, hematocrit, and
red blood cells have insufﬁcient iron stores. Red cell distribution width is an indicator of iron deﬁciency
in adult Fontan patients and it correlates with lower exercise capacity. Elevated ferritin levels in adult
patients after Fontan surgery are associated with liver failure.
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Introduction
The Fontan procedure, described for the ﬁrst time in 1971, is
presently awidely acceptedmethodof treating patientswith single
ventricle heart [1]. The absence of the ventricle that pumps blood to
the pulmonary bed results in restricted pulmonary venous return,
which in turn causes a decrease in systemic ventricle preload [2].
Somepatients demonstrate a gradual decrease in arterial blood sat-
uration, increased hematocrit (HCT) values, and cyanosis. This is
served.
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ssociated with the presence of abnormal arterial-venous ﬁstulas
n the pulmonary bed, intrahepatic venous shunts, increased pul-
onary resistance, atrioventricular valve regurgitation, impaired
ystolic and diastolic function of the systemic ventricle, and intrac-
rdiac shunts, e.g. fenestration [3]. Earlier reports described the
revalence of cyanosis in adult patients after the Fontan procedure
s 20–25% [4,5]. Erythrocytosis is a physiological increase in red
ell number as a consequence of chronic hypoxia. This is a compen-
atory mechanism, leading to increase in tissue oxygen supply [6].
Iron-deﬁciency anemia is the most common type of anemia;
t may result from blood loss, diet iron deﬁciency, abnormal
bsorption, and increased requirements. Hemoglobin (HGB) con-
entration is themost reliable indicator of anemia at the population
evel [7,8]. Previous investigations indicated high frequency of ane-
ia in patients with congenital cyanotic heart defects [9]. More
han one-third of patients with congenital cyanotic heart defects
re believed to be iron deﬁcient [10]. Collins et al. [11] reported that
nemia is common in patients with complex congenital heart dis-
ases and ventricular dysfunction, in particular those with Fontan
hysiology. Moreover, anemia is associated with increased mortal-
ty rates in this group of patients [10]. Numerous studies on anemia
npatientswith congenital heart defects andheart failurewereper-
ormed in subjects with biventricular hearts [7,11–15]. The cause
f anemia in adult patients after Fontan operation remains unclear,
nd its inﬂuenceonexercise capacityhasnot beenexamined. To the
est of our knowledge, there are few investigations addressing the
ssessment of hematological and iron-related parameters in adult
ontan patients.
The aim of this study was to characterize hematologic changes
nd iron metabolism in adult Fontan patients. We also searched
or the associations between these parameters and physical per-
ormance in the study group.
aterials and methods
tudy participants
All the study patients were recruited consecutively at the
ohn Paul II Hospital in Krakow, Poland, between August 2012 and
ecember 2012. Patients were eligible if they were aged ≥18 years,
ad Fontan physiology, and were in stable clinical condition for at
east 3 months before enrollment to the study. The main exclusion
riteria were renal insufﬁciency, neoplasmatic diseases, infec-
ion, inﬂammation, major trauma within the past three months,
regnancy, diabetes, and alcohol abuse. In addition, 30 age-
nd sex-matched healthy volunteers were recruited. None of the
articipantswereon iron supplementationorwerephlebotomized.
tudy protocol
Clinical and demographic variables were extracted from the
atients’ medical records. In every patient we assessed labora-
ory parameters, body mass index, arterial oxygen saturation, and
jection fraction of the systemic ventricle. Body mass index was
alculated as mass (kg)/height (m)2. Ejection fraction of the single
entricle (EFSV) was assessed using the Simpson method (Vivid 7,
E Medical Systems No 4183V7, Milwaukee, WI, USA). Cardiopul-
onary exercise test (CPET) was performed using a modiﬁed Bruce
rotocol (ZAN-600 type USB No. 6660161). During the test, elec-
rocardiogram, blood pressure, clinical symptoms, and duration of
xercise were recorded. The monitored gas parameters included
xercise time (T, min), peak oxygen uptake (VO2peak, ml/kg/min
nd %predicted value) and oxygen uptake at anaerobic threshold
VO2AT, %predicted value). Oxygen saturation (SatO2, %) was mea-
ured by pulse oximetry in the room air.Cardiology 64 (2014) 384–389 385
The study protocolwas approved by the local Ethical Committee
and each subject granted informed consent to participate in the
investigation.
Laboratory investigations
Bloodsampleswerecollected fromtheantecubital veinbetween
07:00h and 09:00h, after overnight fasting for at least 12h.
White blood cells (WBC), platelet count, red blood cells (RBC),
HCT, HGB, mean corpuscular volume (MCV), mean corpuscular
hemoglobin (MCH), mean corpuscular hemoglobin concentra-
tion (MCHC), red cell distribution width (RDW), platelet count,
total protein, alanine aminotransferase (ALT), creatinine, gamma-
glutamyltranspeptidase (GGTP), alkaline phosphatase (ALP), C-
reactive protein (CRP), uric acid, creatinine, estimated glomerular
ﬁltration rate (eGFR), cystatin C, N-terminal pro-B-type natriuretic
peptide (NT-proBNP), bilirubin, and international normalized
ratio (INR) were assayed using routine laboratory techniques.
Hyaluronic acid (HA) levels were measured with a commercial
enzyme-linked immunosorbent assay (ELISA) kit (R&D systems,
Minneapolis, MN, USA) according to the manufacturer’s instruc-
tions. This sandwich assay uses human recombinant aggrecan as
the immobilized capture phase for HA in the subject’s serum sam-
ple and is designed to measure >35kDa molecules of HA. Mean
intra-assay coefﬁcient of variation was 5.9%. Iron concentration
values (normal range: men 6.6–26mol/l, women 11–28mol/l)
and unsaturated iron-binding capacity (UIBC) (normal range:
20–62mol/l) were determined by the colorimetric method.
Total iron-binding capacity (TIBC) (normal range: 45–70mol/l)
was calculated as TIBC (mol/l) = Iron (mol/l) +UIBC (mol/l).
Transferrin saturation (TSAT) (normal range: 20–40%) was cal-
culated as TSAT (%) = iron (mol/l)/TIBC (mol/l)×100. Ferritin
(normal range: 30–400g/l) was determined by the latex particle-
enhanced immunoturbidimetric method (Cobas 6000, Roche,
Rotkreuz, Switzerland). Anemia was deﬁned as HGB concentration
<13g/dl in males and <12g/dl in females [9].
Statistical analysis
Continuous variables are expressed as mean± SD. Categori-
cal variables are described as counts and percentages. Patients
after Fontan operation and controls were compared using the
Mann–Whitney U-test for the continuous variables and with the
chi square test for categorical variables. Correlations between
the individual parameters were calculated using the Spearman
rank test. Factors that determine RDW, ferritin level, and VO2peak
were analyzed usingmultiple logistic regression analysis. A p-value
<0.05 was considered statistically signiﬁcant. The statistical anal-
yses were performed with the PQStat version 1.4.2.324 software
(Poznan´/Plewiska, Poland).
Results
Group characteristics
We enrolled 32 Fontan patients (11 men, 20 women) aged
25±4.5 years. The mean age at Fontan operation was 5.3±3.5
(2–14) years. The mean follow-up time was 19.6±5.2 (15–30)
years. Underlying cardiac malformations were as follows: 14 (44%)
patients with tricuspid atresia, 10 (31%) patients with pulmonary
atresia and ventricular septal defect, two (6%) patients with double
outlet right ventricle and left ventricular hypoplasia, and six sub-
jects (19%) with right ventricular hypoplasia. Modiﬁcation of the
Fontan operation included direct right atrium–pulmonary artery
connection in four (12%) patients and total cavopulmonary connec-
tion (TCPC) by means of intraatrial lateral tunnel in the remaining
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(r=0.45, p=0.01), MCH (r=0.53, p=0.002) and negatively with
NYHA class (r=−0.49, p=0.03) and RDW (r=−0.49, p=0.05). Fer-
ritin showed a positive association with WBC (r=0.64, p<0.001),
HGB (r=0.7, p=0.007), MCHC (r=0.58, p<0.001), ALT (r=0.61,
Table 2
Hematological and iron-related parameters in Fontan patients and controls.
Variable Fontan
N=32
Controls
N=30
p
WBC (103/l) 5.3 ± 1.6 5.8 ± 1.3 0.1
RBC (109/l) 6.0 ± 2.1 4.8 ± 0.4 <0.001
Hg (g/dl) 16.7 ± 1.4 14.2 ± 1.3 <0.001
HCT (%) 49 ± 3.4 42.1 ± 3.1 <0.001
MCV (fL) 84.8 ± 11.6 87.2 ± 3.0 0.486 L. Tomkiewicz-Pajak et al. / Jour
8 (88%) patients. The fenestration was present in 10 (31%) TCPC
atients. Majority of the patients (30, 94%) had single ventricle
f the left ventricular morphology and the remaining two (6%)
ad morphologically right systemic ventricle. Seven (22%) patients
ere in New York Heart Association (NYHA) class I, 22 (69%) in
YHA class II, and three patients (9%) in NYHA class III. Ten (32%)
atientswere treatedwithwarfarin, two (6%)with enoxaparin, and
5 (47%) with aspirin.
The Fontan patients did not differ from the controls with regard
o age, sex, and BMI. The results are presented in Table 1. Compared
o the controls, the Fontan patients had lower EFSV (51.1±5.6% vs.
9.6±5.4%, p<0.001), SatO2 (87.6±7% vs. 96.9±1.5%, p<0.001),
O2peak (23.7±6.4ml/kg/min vs. 49.3±8.4ml/kg/min, p<0.001
nd 61.4±16.8% vs. 121.6±19.6%, p<0.001), VO2AT (46.2±16.2%
s. 55.7±7%, p=0.005), T (15.3±2.7min vs. 17±2.5min, p=0.01),
nd higher ALT (28.5±12.1 IU/l vs. 21.5±6.1 IU/l, p=0.007),
ystatin C (1.0±0.3mg/l vs. 0.84±0.1mg/l, p=0.01), bilirubin
evel (21.7±15.1mol/l vs. 9.2±4.6mol/l, p<0.001), GGTP
75.7±46.0U/l vs. 19.3±9.6U/l, p<0.001), ALP (67.4±21.2U/l vs.
1.2±16.6U/l, p<0.001), INR (1.2±0.2 vs. 1±0.1, p<0.001), HA
65.8±59.3ng/ml vs. 27.0±23.3ng/ml, p<0.001) as well as NT-
roBNP (320.1±544pg/ml vs. 54.3±26.9pg/ml, p=0.009). There
ere no differences in total protein, creatinine, eGFR, and CRP lev-
ls. We have not diagnosed anemia in any Fontan patients. Among
2 analyzed patients low iron values were noted in four (12%),
f which two (6%) presented with symptoms of protein-losing
nteropathy manifested as edema of the lower extremities and
scites.
ematologic alterations
The Fontan patients had higher RBC (6.0±2.1×109/l vs.
.8±0.4×109/l, p<0.001), HGB (16.7±1.4 g/dl vs. 14.2±1.3 g/dl,
< 0.001), HCT (49±3.4% vs. 42.1±3.1%, p<0.001), and RDW
14.3±2.4% vs. 12.8±0.5%, p<0.001), while MCV, MCH, and
CHC were similar in both the groups. The results are shown
able 1
aseline clinical and laboratory characteristics of Fontan patients and controls.
Fontan
N=32
Controls
N=30
p
Age (years) 24.9±6 25.4±5.7 0.09
Male, n (%) 20 (66) 22 (69) 0.7
BMI (kg/m2) 22±1.8 21.7±2.6 0.2
SVEF (%) 51.1±5.6 69.6±5.4 <0.001
SatO2 (%) 87.6±7 96.9±1.5 <0.001
ALT (IU/l) 28.5±12.1 21.5±6.1 0.007
GGTP (U/l) 75.7±46.0 19.3±9.6 <0.001
HA (ng/ml) 65.8±59.3 27.0±23.3 <0.001
ALP (U/l) 67.4±21.2 51.2±16.6 <0.001
Total protein (g/dl) 73.8±8.9 74.1±2.6 0.2
Albumin (g/dl) 49.4±4.7 48.2±5.8 0.4
Creatinine (mol/l) 82.8±15 77.1±12.9 0.5
GFR (ml/min/m2) 107.2±17.6 109.3±10.9 0.6
Cystatin C (mg/l) 1.0±0.3 0.84±0.1 0.01
Bilirubin (mol/l) 21.7±15.1 9.2±4.6 <0.001
INR 1.2±0.2 1±0.1 <0.001
CRP (mg/l) 2.3±2.2 2.0±1.6 0.4
Uric acid (mol/l) 371.3±161.4 312.9±96 0.09
NT-proBNP (pg/ml) 320.1±544 54.3±26.9 0.009
VO2peak (ml/kg/min) 23.7±6.4 49.3±8.4 <0.001
VO2peak (%N) 61.4±16.8 121.6±19.6 <0.001
VO2AT (%) 46.2±16.2 55.7±7 0.005
T (min) 15.3±2.7 17±2.5 0.01
MI, body mass index; SVEF, single ventricle ejection fraction; SatO2, oxygen satu-
ation; ALT, alanine aminotransferase; GGTP, gamma-glutamyltranspeptidase; HA,
yaluronic acid; ALP, alkaline phosphatase; GFR, glomerular ﬁltration rate; INR,
nternationalnormalized ratio; CRP, C-reactiveprotein;NT-proBNP,N-terminal pro-
-type natriuretic peptide; VO2peak, peak oxygen uptake; VO2AT, oxygen uptake at
naerobic threshold; T, exercise time.Cardiology 64 (2014) 384–389
in Table 2. There were no correlations between SatO2 and RBC,
HCT, and HGB. Interestingly, seven (22%) Fontan patients had RDW
above the normal range (14.5%). RDW correlated negatively with
SatO2 (r=−0.49; p=0.008), SVEF (r=−0.52, p=0.02), ALT (r=−0.4,
p=0.02), MCH (r=−0.48, p=0.04), iron (r=−0.49, p=0.05), TSAT
(r=−0.4, p=0.04), and VO2peak (r=−0.5, p=0.001) and positively
with CRP (r=0.4, p=0.04) andwith follow-up time (r=0.4, p=0.04).
The results are shown in Figs. 1 and 2. There was no correlation
between RDW and NT-proBNP.
Iron metabolism
When compared to the controls, the Fontan patients had
higher UIBC (46.1±12.6mol/l vs. 38.4±11.9mol/l, p=0.02),
TIBC (62.8±9.8mol/l vs. 57.8±8.5mol/l, p=0.04) and lower
TSAT (27.4±11.4% vs. 34.6±13.4%, p=0.03) (Table 2). There were
no differences in iron and ferritin level between the groups. Iron
level correlated positively with TSAT (r=0.89, p<0.001), MCVMCH (fL) 29.6 ± 1.7 29.4 ± 1.3 0.7
MCHC (mmol/l) 33.1 ± 5.5 33.7 ± 1.4 0.3
RDW (%) 14.3 ± 2.4 12.8 ± 0.5 <0.001
Platelet count (103/l) 131.9 ± 36.8 224.5 ± 48.3 <0.001
Iron (mol/l) 16.7 ± 6.4 19.4 ± 6.5 0.1
Ferritin (g/ml) 112.6 ± 78.6 86.6 ± 59.1 0.1
UIBC (mol/l) 46.1 ± 12.6 38.4 ± 11.9 0.02
TIBC (mol/l) 62.8 ± 9.8 57.8 ± 8.5 0.04
TSAT (%) 27.4 ± 11.4 34.6 ± 13.4 0.03
WBC, white blood cells; RBC, red blood cells; Hg, hemoglobin; HCT, hematocrit;
MCV,mean corpuscular volume;MCH,mean corpuscular hemoglobin;MCHC,mean
corpuscular hemoglobin concentration; RDW, red cell distribution width; UIBC,
unsaturated iron binding capacity; TIBC, total iron binding capacity; TSAT, trans-
ferrin saturation.
Correlation between RDW and Oxygen Saturation
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Fig. 1. Correlationbetween redcell distributionwidth (RDW)andoxygensaturation
in Fontan patients.
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Table 3
Univariate analysis for RDW, VO2peak, and ferritin level.
Variables RDW VO2peak Ferritin
ˇ p ˇ p ˇ p
Age (years) 0.3 0.1 −0.29 0.1 0.06 0.8
SVEF (%) −0.44 0.01 0.45 0.01 0.09 0.6
SatO2 (%) −0.6 <0.001 0.27 0.2 0.31 0.09
ALT (IU/l) −0.33 0.07 0.28 0.1 0.5 0.004
GGTP (U/l) −0.15 0.5 0.05 0.8 0.43 0.03
HA (ng/ml) 0.45 0.01 −0.4 0.03 0.29 0.1
ALP (U/l) 0.37 0.04 −0.37 0.04 0.1 0.06
Total protein (g/dl) −0.1 0.6 0.2 0.3 0.23 0.2
Albumin (g/dl) −0.35 0.05 0.43 0.02 0.26 0.2
Creatinine (mol/l) 0.3 0.05 −0.15 0.5 0.26 0.2
eGFR (ml/min/m2) −0.6 <0.001 0.37 0.6 0.1 0.6
Cystatin C (mg/l) 0.75 <0.001 −0.42 0.02 −0.28 0.1
Bilirubin (mol/l) 0.01 0.9 0.3 0.1 −0.004 0.9
INR 0.1 0.6 −0.35 0.07 −0.05 0.8
CRP (mg/l) 0.27 0.2 −0.3 0.2 −0.17 0.4
Uric acid (mol/l) 0.56 0.001 −0.37 0.05 −0.22 0.2
NT-proBNP (pg/ml) 0.27 0.2 0.04 0.9 0.08 0.7
VO2peak (ml/kg/min) −0.48 0.01 0.1 0.6
VO2peak (%N) −0.53 0.007 0.2 0.4
VO2AT (%) −0.31 0.1 0.48 0.009 0.28 0.1
T (min) −0.58 0.001 0.8 <0.001 0.1 0.6
WBC (103/l) −0.45 0.01 0.09 0.6 0.46 0.01
RBC (109/l) −0.58 0.001 0.1 0.6 0.04 0.8
Hg (g/dl) −0.22 0.2 −0.1 0.6 0.47 0.006
HCT (%) −0.07 0.7 −0.31 0.1 0.35 0.5
MCV (fL) −0.58 0.001 0.38 0.04 0.21 0.3
MCH (fL) −0.36 0.05 0.41 0.03 0.32 0.08
MCHC (mmol/l) −0.14 0.5 0.35 0.07 0.26 0.2
RDW (%) −0.48 0.01 −0.33 0.07
Platelet count
(103/l)
0.07 0.7 −0.07 0.7 0.14 0.4
Iron (mol/l) −0.4 0.03 0.22 0.3 0.4 0.03
Ferritin (g/ml) −0.33 0.07 0.1 0.6
UIBC (mol/l) 0.38 0.4 −0.24 0.2 −0.43 0.02
TIBC (mol/l) 0.21 0.3 −0.16 0.4 −0.42 0.02
TSAT (%) −0.38 0.04 0.21 0.3 0.4 0.01
Postoperative time
(years)
0.4 0.03 −0.19 0.3 0.2 0.3
NYHA 0.38 0.04 −0.42 0.02 −0.34 0.06
SVEF, single ventricle ejection fraction; SatO2, oxygen saturation; ALT, alanine
aminotransferase;GGTP, gamma-glutamyltranspeptidase;HA,hyaluronic acid;ALP,
alkaline phosphatase; eGFR, estimated glomerular ﬁltration rate; INR, international
normalized ratio; CRP, C-reactive protein; NT-proBNP, N-terminal pro-B-type natri-
uretic peptide; VO2peak, peak oxygen uptake; VO2AT, oxygen uptake at anaerobicig. 2. Correlation between red cell distribution width (RDW) and oxygen uptake
VO2 peak) in Fontan patients.
< 0.001), TSAT (r=0.42, p=0.02), and GGTP (r=0.4, p<0.04) and
negative association with TIBC (r=−0.55, p=0.001) and UIBC
r=−0.54, p=0.002). The results are shown in Fig. 3. Univariate
nalysis for RDW, VO2peak, and ferritin level is shown in Table 3.
In the group of patients with RDW above 14.5%, compared to
atients with normal range, signiﬁcantly lower values of SatO2
83.1±10.8% vs. 89.3±4.8%; p=0.04) and iron (12.2±4.6mol/l
s. 18.5±5.9mol/l; p=0.02) were observed (Fig. 4). We did not
ote any differences in hematological and iron-related parameters
n the groups of Fontan patients taking vs. not takingwarfarin (data
ot shown).
To determine the independent effect of clinical and labora-
ory variables, the stepwise regression analysis for RDW, VO2peak,
nd ferritin as dependent variables was performed. The multi-
ariate model showed that SatO2 (ˇ =−0.29, p=0.03) and cystatin
(ˇ =0.65, p<0.001) were the independent predictors of RDW
R2 =0.6, p<0.001). Interestingly, ALT (ˇ =0.44, p=0.01) was an
ndependent predictor of ferritin level (R2 =0.36, p=0.007). RDW
2as an independent predictor of oxygen uptake (R =−0.39,
= 0.008).
Correlation between Ferritin and ALT
0 50 100 150 200 250 300 350
Ferritin
0
10
20
30
40
50
60
70
80
AL
T
0.95 CI
ig. 3. Correlation between alanine aminotransferase (ALT) and ferritin levels in
ontan patients.
threshold; T, exercise time; WBC, white blood cells; RBC, red blood cells; Hg,
hemoglobin; HCT, hematocrit; MCV, mean corpuscular volume; MCH, mean cor-
puscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; RDW,
red cell distribution width; UIBC, unsaturated iron binding capacity; TIBC, total iron
binding capacity; TSAT, transferrin saturation; NYHA, New York Heart Association.
Fig. 4. Iron levels in Fontan patients with red cell distribution width (RDW) in
normal range and with RDW above 14.5%.
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iscussion
In the present studywe demonstrate the changes in hematolog-
cal and iron-related parameters in adult patients late after Fontan
peration. We conﬁrm higher RBC count, RDW, HGB, and HCT lev-
ls and iron deﬁciency as evidenced by increased levels of TIBC and
IBC, and decreased TSAT compared to the controls. Furthermore,
e present an association between RDW and exercise tolerance in
dult Fontan patients.
The therapeutic goal of the Fontan procedure is the normal-
zation of the volume load of the single ventricle and separation
f the pulmonary and systemic circulation, thus achieving normal
r near-normal blood oxygenation [2]. Compared to the controls,
he Fontanpatients demonstrated signiﬁcantly lower arterial blood
aturation. It may result from a progressive drop in single ventri-
le function, a rise in pulmonary pressure, and right-to-left shunt
hrough an atrial fenestration or venovenous collaterals [3]. In
he presented group, the Fontan patients showed a signiﬁcantly
mpaired systolic function of the systemic ventricle when com-
ared to the control subjects. A patent fenestration was present in
0%of thepatients.Asa result of chronic tissuehypoxia, erythropoi-
tin production increases,which leads to an increase in the number
f red blood cells and secondary polyglobulia. However, we did not
nd the correlation between HGB and oxygen saturation. Broberg
t al. [6] demonstrated that nonoptimal relation between these
ariables may result from inadequate erythropoiesis in patients
ith cyanotic congenital heart diseases. Iron, foliate, or vitamin
12 deﬁciency, increased erythropoietin or a right-shifted oxygen-
GB curve might alert this relation [6,10]. Anemia is common in
ohorts of adult patients with cyanotic congenital heart diseases,
anging from 25% to 60%, depending on the study [9,11,13]. The
ause of anemia in this group of patients is multifactorial and
nclear [11,14–16]. Importantly, in the present study, we have not
iagnosed anemia in the Fontan patients. In the earlier investi-
ation, Collins et al. [11] detected anemia in 48% of adult Fontan
atients (mean age 34.8±8 years). In the above report, hypona-
remia, a decreased renal function, and the use of warfarin were
he independent predictors of anemia. In our study, the patients
ere younger (mean age 24.9±6 years) in relation to the stud-
es reported previously [7,11]. The risk of anemia development
ncreases with deteriorating renal function [15,16]. In the present
tudy, we have not observed differences in creatinine concentra-
ions; however, cystatin C level was higher in the Fontan group.
Although anticoagulation increases the risk of blood loss, we
lso have not noted a history of chronic hemorrhage and we have
ot foundanydifferences inhematological and iron-relatedparam-
ters in the groups of patients taking vs. not taking warfarin.
The most common cause of anemia in patients with congeni-
al heart diseases is iron deﬁciency [10,14]. In the present study,
o differences in serum iron levels in the Fontan patients com-
ared to the controls were observed. The literature on the subject
acks data on serum iron levels in adult Fontan patients. Yetman
nd Everitt [17] describe the case of an adult Fontan patient with
ron deﬁciency anemia who developed protein-losing enteropa-
hy. Following intravenous iron administration, the hematological
arameters improved and symptoms associated with protein-
osing enteropathy diminished. In the present study, low iron
alues were noted in four (13%) patients, of which two (6%) pre-
ented with symptoms of protein-losing enteropathy, manifested
s edema of the lower extremities and ascites. Moreover, low iron
evel noted in the investigated group was associated with more
ntensiﬁed symptoms of heart failure. Iron concentration under-
oes daily variations and shows considerable individual biological
ersatility, which makes it difﬁcult to assess iron metabolism. In
he present study, we demonstrated iron deﬁciency in the Fontan
atients compared to the control group. There was a signiﬁcantlyCardiology 64 (2014) 384–389
higher total iron binding and unsaturated iron binding capacity, as
well as decreased transferrin saturation. Ferritin is the major iron-
storing protein. However, a well-known limitation is that it is also
an acute-phase protein and its level may be increased in infective
or inﬂammatory diseases independently from the iron status [10].
In our study, the principal factor determining the level of ferritin
in Fontan patients was ALT level. Kowdley et al. [18] demonstrated
that an increased level of ferritin concentration (>1.5× upper limit
of the normal value) is an independent index of liver damage and
should be applied as a useful non-invasive test identifying individ-
uals at risk of nonalcoholic steatohepatitis and high-grade ﬁbrosis.
Similarly, Wojtowicz-Chomicz et al. [19] noted high ferritin values
in patientswithnonalcoholic steatohepatitis and alcoholic liver cir-
rhosis. Theanalyzedgroupof Fontanpatientsdemonstratedsignsof
liver damage, conforming to earlier reports [20,21]. The major fac-
tor that causes liver failure in Fontan patients is long-term hepatic
venous congestion. Camposilvan et al. [22] reported that hepatic
abnormalities were found in up to 53% of Fontan patients.
RDW deﬁnes the degree of anisocytosis. It is particularly use-
ful in diagnosing the early phase of anemia, when the value of
MCV is still normal [9]. A recent study has described elevated
RDW in patients with heart failure, resulting from multiple con-
ditions that culminated in ineffective erythropoiesis or red blood
cells destruction [23]. Emans et al. [24] conﬁrmed that RDW is
associatedwith heart failure events in an apparently healthy popu-
lation. Furthermore, highRDWlevelswere associatedwithphysical
inactivity in this group. In the present study, the Fontan patients
have a high value of RDW. Moreover, peripheral oxygen saturation
and cystatin C level were an independent determinant of RDW.
This is in agreement with a previous study showing an ineffec-
tive erythropoiesis and impaired renal function as determinants
of high RDW in heart failure [25]. High RDW values were also
associated with low iron levels. One possible explanation to this
ﬁnding is that RDW might reﬂect the disease’s severity associated
with (i) surgery-related iron loss, (ii) reduced gastrointestinal iron
uptake, and (iii) increased gastrointestinal iron loss associatedwith
protein-losing enteropathy [5,11,17]. Similarly,Martinez-Quintana
andRodriguez-Gonzalez [9] demonstrated that RDWis an inexpen-
sive, easy to determine parameter, which allows the diagnosis of
early phases of iron deﬁciency in patients with congenital cyan-
otic heart defects. Peak oxygen consumption is considered as the
gold standard to assess exercise performance. In our study, peak
oxygenuptakeand thedurationofCPET inFontanpatientswere sig-
niﬁcantly decreased. Diminished exercise capacity was associated
with an early start of anaerobic metabolism. Moreover, RDW was
an independent predictor of diminished exercise capacity in adult
Fontan patients. Van Craenenbroeck et al. [23] demonstrated that
RDW was associated with lower exercise capacity in patients with
heart failure independent of other widely accepted determinants
suchasage,HGB, renal function, andNT-proBNPvalues. Themecha-
nismbywhichRDWis associatedwith impairedexercise capacity is
multifactorial and poorly understood. One might expect that RDW
reﬂectsdisease severity andmightnotbe causal.However, lowoxy-
gen saturation may lead to inadequate erythropoiesis, resulting in
RDW increase, which in turn may decrease oxygen supply to the
muscles [24].
The results discussed above may have important implications
for the treatment of Fontan patients. However, more extensive
studies with a higher number of subjects are needed to determine
iron deﬁciency in this population. The inﬂuence of the potentially
beneﬁcial effects of iron supplementation on the clinical status, the
course of the disease, and the prognosis of Fontan patients should
be addressed in future prospective clinical trials [26].
Several limitations of the study should be acknowledged. First,
the number of the patients in the study was small and heteroge-
neous with respect to cardiac diagnosis and Fontan surgery type.
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ypochromia and microcytosis could have been masked by other
actors, such as vitamin B12 and/or foliate deﬁciency [14]. We have
ot measured vitamin B12, foliate, homocysteine, and erythropoi-
tin, which can be considered as another limitation of the study.
onclusion
In the present study we show that in adult patients after Fontan
peration, despite having increased HGB, HCT, and red blood cells,
nsufﬁcient iron stores were detected. RDW is an indicator of
ron deﬁciency in those patients and correlates with lower phys-
cal activity. Elevated ferritin levels in adult patients after Fontan
urgery are associated with liver failure.
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